Cognitive function · public health programmes to regularly treat all children aged 16 years or less
1 finding from 1 review
Physical fitness ‐ not measured · public health programmes to regularly treat all children aged 16 years or less
1 finding from 1 review
School attendance · public health programmes to regularly treat all children aged 16 years or less
1 finding from 1 review
School performance · public health programmes to regularly treat all children aged 16 years or less
1 finding from 1 review
Death (between ages 1 and 6 years) · public health programmes to regularly treat all children aged 16 years or less
Multiple doses of deworming drugs showed no clear difference in mortality (between ages 1 and 6 years) compared with placebo (low certainty).
1 finding from 1 review
Weight (kg) · public health programmes to regularly treat all children aged 16 years or less
1 finding from 1 review
Intervention not reported
Microfilaraemia (mf) prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in microfilaraemia (mf) prevalence (high certainty).
1 finding from 1 review
Intervention not reported
Mf density · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
1 finding from 1 review
Intervention not reported
Antigenaemia prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in antigenaemia prevalence (high certainty).
1 finding from 1 review
Intervention not reported
Antigen density · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
1 finding from 1 review
Intervention not reported
Adult worm prevalence detected by ultrasound ‐ not measured · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Microfilaraemia (mf) prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in microfilaraemia (mf) prevalence (moderate certainty).
1 finding from 1 review
Intervention not reported
Mf density · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
1 finding from 1 review
Intervention not reported
Mf density · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
1 finding from 1 review
Intervention not reported
Antigenaemia prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in antigenaemia prevalence (high certainty).
1 finding from 1 review
Intervention not reported
Antigen density · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
1 finding from 1 review
Intervention not reported
Mf density · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
1 finding from 1 review
Intervention not reported
Adult worm prevalence detected by ultrasound · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in adult worm prevalence detected by ultrasound (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · people with lymphatic filariasis or communities where lymphatic filariasis is endemic
The intervention showed no clear difference in adverse events (high certainty).
1 finding from 1 review